The SensorBelt is an alternative to placing an array of sensors on a patient's abdomen during a PillCam capsule endoscopy procedure.
Given Imaging Ltd. (Nasdaq: GIVN; TASE: GIVN) has obtained US Food and Drug Administration (FDA) approval for the use of the company's SensorBelt product in patients with a Body Mass Index (BMI) of up to 43.3 kg/sq.m., based on the results of a recent clinical trial. The SensorBelt is a convenient, easy-to-use alternative to placing an array of sensors on a patient's abdomen during a PillCam capsule endoscopy procedure.
Given Imaging introduced the SensorBelt in 2009. It is fitted over a single layer of natural fiber clothing worn by the patient and employs easy-fasten straps for quick adjustments and removal. The sensors are incorporated within the belt and eliminate the need for a nurse to attach sensors or prepare a patient's abdomen for the procedure.
Given Imaging's share price fell 2.5% in early trading on Nasdaq to $19.53, giving a market cap of $584 million, after falling 1.6% on the TASE to NIS 71.09.
Published by Globes [online], Israel business news - www.globes-online.com - on February 22, 2011
© Copyright of Globes Publisher Itonut (1983) Ltd. 2011